Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: Pharmacokinetic assay of CAN-C™ N-acetylcarnosine prodrug lubricant eye drops for cataract prevention

Drugs in R and D

Volumn 6, Issue 6, 2005, Pages 345-369

  Babizhayev, Mark A ^a,b  

^a Innovative Vision Products Incorporated   (United States)

^b MOSCOW HELMHOLTZ RESEARCH INSTITUTE OF EYE DISEASES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CAN C; CARBOXYMETHYLCELLULOSE; CARNOSINE; DIPEPTIDE; EYE DROPS; IMIDAZOLE; LIPID PEROXIDE; N ACETYLCARNOSINE; NU EYES; PLACEBO; PRODRUG; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG EFFECT; DRUG FORMULATION; ELECTRON MICROSCOPY; EYE DISEASE; EYE TOXICITY; FEMALE; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LENS; LIPID PEROXIDATION; MALE; MATURATION; NONHUMAN; PARAMETER; PRIORITY JOURNAL; TIMED DRUG RELEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CARNOSINE; CATARACT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LENS, CRYSTALLINE; LIPID PEROXIDATION; LIPOSOMES; LUBRICATION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PRODRUGS; RABBITS;

EID: 27744576894     PISSN: 11745886     EISSN: 11745886     Source Type: Journal    
DOI: 10.2165/00126839-200506060-00004     Document Type: Article

References (88)

1. Vision Research, a national plan. 1999-2002 report of the national advisory council, published by US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Eye Institute, 1998: 59
2. Kupfer C, Underwood B, Gillen T. Leading causes of visual impairment worldwide. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology: basic sci. Philadelphia (PA): WB Saunders & Co, 1994: 1249-55
3. Spector A. Oxidative stress and disease. J Ocul Pharmacol 2000; 16: 193-201
4. Dische Z, Zil H. Studies on the oxidation of cysteine to cystine in lens proteins during cataract formation. Am J Ophthalmol 1951; 34: 104-13
5. Spector A, Roy D. Disulfide-linked high molecular weight protein associated with human cataract. Proc Natl Acad Sci U S A 1978; 75: 3244-8
6. Garner MH, Spector A. Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. Proc Natl Acad Sci U S A 1980; 77: 1274-7
7. Augusteyn RC. Protein modification in cataract: possible oxidative mechanisms. In: Duncan G, editor. Mechanisms of protein modification in the human lens. New York: Academic Press, 1981: 72-115
8. Varma SD, Kumar S, Richards RD. Light-induced damage to ocular lens cation pump: prevention by vitamin C. Proc Natl Acad Sci U S A 1979; 76: 3504-6
9. Varma SD, Srivastava VK, Richards RD. Photoperoxidation in lens and cataract formation: preventive role of superoxide dismutase, catalase and vitamin C. Ophthalmic Res 1982; 14: 167-75
10. Varma SD, Chand D, Sharma YR, et al. Oxidative stress on lens and cataract formation: role of light and oxygen. Curr Eye Res 1984; 3: 35-57
11. Giblin FJ, McCready JP, Schrimscher L, et al. Peroxide-induced effects on lens cation transport following inhibition of glutathione reductase activity in vitro. Exp Eye Res 1987; 45: 77-91
12. Harding JJ. Disulphide cross-linked protein of high molecular weight in human cataractous lens. Exp Eye Res 1973; 17: 377-83
13. 2 and chelated iron. Free Radic Biol Med 1989; 7: 499-505
14. Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res 1984; 3: 67-81
15. Babizhayev MA, Deyev AI, Linberg LF. Lipid peroxidation as a possible cause of cataract. Mech Ageing Dev 1988; 44: 69-89
16. Clayton RM, Cuthbert J, Duffy J, et al. Some risk factors associated with cataract in S.E. Scotland: a pilot study. Trans Ophthalmol Soc 1982; 102: 331-6
17. Harding JJ, Crabbe MJC. The lens: development, proteins, metabolism and cataract. In: Dawson, H, editor. The eye. London: Academic Press, 1984 Vol. 1B: 207-492.
18. Costagliola C, Iuliano G, Menzione M, et al. Systemic human diseases as oxidative risk factors in cataractogenesis: I. Diabetes. Ophthalmic Res 1988; 20: 308-16
19. Costagliola C, Iuliano G, Menzione M, et al. Systemic human diseases as oxidative risk factors in cataractogenesis: II. Chronic renal failure. Exp Eye Res 1990; 51: 631-5
20. Simonelli F, Nesti A, Pensa M, et al. Lipid peroxidation and human cataractogenesis in diabetes and severe myopia. Exp Eye Res 1989; 49: 181-7
21. Babizhayev MA, Deyev AI. Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim Biophys Acta 1989; 1004: 124-33
22. Babizhayev MA. Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing. Biochim Biophys Acta 1996; 1315: 87-99
23. Babizhayev MA. Accumulation of lipid peroxidation products in human cataracts. Acta Ophthalmol (Copenh) 1989; 67: 281-7
24. Bhuyan KC, Master RWP, Coles RS, et al. Molecular mechanisms of cataractogenesis: IV. Evidence of phospholipid malondialdehyde adduct in human senile cataract. Mech Ageing Dev 1986; 34: 289-96
25. Borchman D, Yappert MC, Rubini RQ, et al. Distribution of phospholipid-malondialdehyde-adduct in the human lens. Curr Eye Res 1989; 8: 939-46
26. Bhuyan KC, Bhuyan DK, Podos SM. Lipid peroxidation in cataract of the human. Life Sci 1986; 38: 1463-71
27. Bhuyan KC, Bhuyan DK, Podos SM. Free radical enhancer xenobiotic is an inducer of cataract in rabbit. Free Radic Res Commun 1991; 12-13: 609-20
28. Mibu H, Nagata M, Hikida M. A study on lipid peroxide-induced lens damage in vitro. Exp Eye Res 1994; 58: 85-90
29. Nishigori H, Lee JW, Yamauchi Y, et al. The alteration of lipid peroxide in glucocorticoid-induced cataract of developing chick embryos and the effect of ascorbic acid. Curr Eye Res 1986; 5: 37-40
30. Yagi K, Komura S, Ihara N, et al. Serum lipid peroxide levels in rats with inherited cataracts. J Appl Biochem 1985; 7: 202-6
31. Zigler JS, Bodaness RS, Gery I, et al. Effects of lipid peroxidation products on the rat lens in organ culture: a possible mechanism of cataract initiation in retinal degenerative disease. Arch Biochem Biophys 1983; 225: 149-56
32. Zigler Jr JS, Gery I, Kessler D, et al. Macrophage mediated damage to rat lenses in culture: a possible model for uveitis-associated cataract. Invest Ophthalmol Vis Sci 1983; 24: 651-4
33. Goosey JD, Tuan WM, Garcia CA. A lipid peroxidative mechanism for posterior subcapsular cataract formation in the rabbit: a possible model for cataract formation in tapetoretinal diseases. Invest Ophthalmol Vis Sci 1984; 25: 608-12
34. Zigler JS, Hess HH. Cataracts in the Royal College of Surgeons rat: evidence for initiation by lipid peroxidation products. Exp Eye Res 1985; 41: 67-76
35. Babizhayev MA, Dainyak BA, Maxina AH. ESR spin label and ultrastructural monitoring of protein-lipid interactions in the lens fiber-cell plasma membranes in relation to human ageing and cataractogenesis. Mech Ageing Dev 1992; 64: 133-47
36. Borchman D, Lamba OP, Salmassi S, et al. The dual effect of oxidation on lipid bilayer structure. Lipids 1992; 27: 261-5
37. Borchman D, Giblin FJ, Leverenz VR, et al. Impact of aging and hyperbaric oxygen in vivo on guinea pig lens lipids and nuclear light scatter. Invest Ophthalmol Vis Sci 2000; 41: 3061-73
38. Borchman D, Lamba OP, Yappert MC. Structural characterization of lipid membranes from clear and cataractous human lenses. Exp Eye Res 1993; 57: 199-208
39. 2+-ATPase in the rabbit lens. Invest Ophthalmol Vis Sci 1989; 30: 1633-7
40. 2+-ATPase activity and membrane lipids in lens epithelial microsomes. Free Radic Biol Med 1999 Jul; 27 (1-2): 177-85
41. Kagan VE. Lipid peroxidation in biomembranes. Boca Raton (FL): CRC Press, 1988: 181
42. Park J, Floyd RA. Lipid peroxidation products mediate the formation of 8-hydroxydeoxyguanosine in DNA. Free Radic Biol Med 1992; 12: 245-50
43. Babizhayev MA. Lipid fluorophores of the human crystalline lens with cataract. Graefes Arch Clin Exp Ophthalmol 1989; 227: 384-91
44. Babizhayev MA. Antioxidant activity of L-carnosine, a natural histidine-containing dipeptide in crystalline lens. Biochim Biophys Acta 1989; 1004: 363-71
45. Kikugawa K, Kato T, Beppu M, et al. Development of fluorescence and cross-links in eye lens crystallin by interaction with lipid peroxy radicals. Biochim Biophys Acta 1991; 1096: 108-14
46. Ferrer JV, Gasco E, Sastre J, et al. Age-related changes in glutathione synthesis in the eye lens. Biochem J 1990; 269: 531-4
47. Cenedella RJ. Lipoproteins and lipids in cow and human aqueous humor. Biochim Biophys Acta 1984; 793: 448-54
48. Cenedella RJ. Source of cholesterol for the ocular lens, studied with U18666A: a cataract-producing inhibitor of lipid metabo-lism. Exp Eye Res 1983; 37: 33-43
49. Kuzuya M, Naito M, Funaki C, et al. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim Biophys Acta 1991; 1096: 155-61
50. Babizhayev MA, Bozzo Costa E. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochim Biophys Acta 1994; 1225: 326-37
51. Yadav S, Rawal UM. Cholesterol and lipid peroxidation in three beta-(2-diethylaminoethoxy)- androst-5-en-17-oneHCl (U18666A) induced cataractogenesis in rats. Indian J Exp Biol 1992; 30: 147-8
52. Babizhayev MA, Seguin M-C, Gueyne J, et al. L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem J 1994; 304: 509-16
53. Dahl TA, Midden WR, Hartman PE. Some prevalent biomolecules as defenses against singlet oxygen damage. Photochem Photobiol 1988; 47: 357-62
54. Boldyrev AA, Dupin AM, Bunin AYa, et al. The antioxidative properties of carnosine, a natural histidine containing dipeptide. Biochem Int 1987; 15: 1105-13
55. Jay JL, Miller DJ, Morrison JD, et al. Histidyl derivatives in rabbit lens and their diminution in human cataract [abstract]. J Physiol Lond 1990; 420: 155
56. Jackson MC, Kucera CM, Lenney JF. Purification and properties of human serum carnosinase. Clin Chim Acta 1991; 196: 193-206
57. Lenney JF, Peppers SC, Kucera-Orallo CM, et al. Characterization of human tissue carnosinase. Biochem J 1985; 228: 653-60
58. O'Dowd JJ, Robins DJ, Miller DJ. Detection, characterization and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle. Biochim Biophys Acta 1988; 967: 241-9
59. Anderson JA, Davis WL, Wei C. Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine. Invest Ophthalmol Vis Sci 1980; 19: 817-23
60. Babizhayev MA, Yermakova VN, Sakina NL, et al. N-acetyl-carnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin Chim Acta 1996; 254: 1-21
61. Babizhayev MA, Yermakova VN, Semiletov Yu A, et al. The natural histidine-containing dipeptide N-acetylcarnosine as an antioxidant for ophthalmic use. Biochemistry (Mosc) 2000; 65: 588-98
62. Babizhayev MA, Deyev AI, Yermakova VN, et al. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R&D 2002; 3 (2): 87-103
63. Babizhayev MA, Deyev AI, Yermakova VN, et al. N-Acetyl-carnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides 2001; 22: 979-94
64. Babizhayev MA, Yermakova VN, Deyev AI, et al. Imidazole containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans. J Anti Aging Med 2000; 3: 43-62
65. Babizhayev MA, Deyev AI, Derevyagin VI. Morphometric evaluation of human lens opacification. J Microsc 1989; 154: 115-27
66. Babizhayev MA, Zhukotskii AV, Sologub AA. Image analysis of the lens opacities induced in developing chick embryo by glucocorticoid. Exp Eye Res 1992; 55: 521-37
67. Babizhayev MA, Deyev AI. Modification of membrane structures in cataract. Vopr Med Khim 1987; 33: 125-32
68. Babizhayev MA, Brodskaya MW. Changes in fibronectin staining in the human lens during ageing and cataractogenesis. Biochim Biophys Acta 1991; 1096: 139-47
69. Reynolds E. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963; 17: 208-12
70. Folch J, Lee M, Sloane-Stanely GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509
71. Chen PS, Toribara TY, Warner H. Microdetermination of Phosphurus. Anal Chem 1956; 28: 1756-8
72. Bolland JL, Koch HP. The course of autooxidation reactions in polyisoprenes and allied compounds. Part IX. the primary thermal oxidation products of ethyl linoleate. J Chem Soc 1945; 7: 445-7
73. Chio KS, Tappel AL. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry (Wash) 1969; 8: 2821-7
74. Rosenfeld L, Spector A. Comparison of polyunsaturated acid levels in normal and mature cataractous human lenses. Exp Eye Res 1982; 35: 69-75
75. Babizhayev MA, Deyev AI, Chernikov AV. Peroxide-metabolizing systems of the crystalline lens. Biochim Biophys Acta 1992; 1138: 11-9
76. Aruoma OI, Laughton MJ, Halliwell B. Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem J 1989; 264: 863-9
77. Costello MJ, Oliver TN, Cobo LM. Cellular architecture in age-related human nuclear cataracts. Invest Ophthalmol Vis Sci 1992; 33: 3209-27
78. Babizhayev, MA, Mirimskii AS, Linberg, LF. Lipid fluorophores of the crystalline lens in cataract. Biofizika 1986; 31: 681-86
79. Horikawa Y, Mibu H, Hikida M. In vitro cataract model induced by lipid peroxide. J Eye (Atarasbii Ganka) 1990; 7: 561-3
80. Hightower KR, McCready J, Borchman D. Membrane damage in UV-irradiated lenses. Photochem Photobiol 1994, 485-590
81. Bhuyan KC, Bhuyan DK, Kuck JFR, et al. Increased lipid peroxidation and altered membrane functions in Emory mouse cataract. Curr Eye Res 1982- 1983; 2: 595-606
82. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon, 1985
83. Babizhayev MA. Method for topical treatment of eye disease and composition and device for said treatment. PCT Patent application. International Publication Number WO 2004/ 028536 A1. International Publication 2004 Apr 8
84. Babizhayev MA, Deyev AI, Yermakova VN, et al. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs R&D 2004; 5 (3): 125-39
85. Seidler NW, Yeargans GS, Morgan TG. Carnosine disaggregates glycated alpha-crystallin: an in vitro study. Arch Biochem Biophys 2004; 427 (1): 110-5
86. Babizhayev MA, Deev AI. Free radical oxidation of lipids and thiol groups in the formation of a cataract. Biofizika 1986; 31 (1): 109-14
87. Aldini G, Carini M, Beretta G, et al. Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? Biochem Biophys Res Commun 2002; 298 (5): 699-706
88. Hobart LJ, Seibel I, Yeargans GS, et al. Anti-crosslinking properties of carnosine: significance of histidine. Life Sci 2004; 75 (11): 1379-89